{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:48:15Z","timestamp":1792270095121,"version":"4.4.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00284-023-03305-0","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T17:01:59Z","timestamp":1682614919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Association Between Inflammatory Bowel Disease and Viral Infections"],"prefix":"10.1007","volume":"80","author":[{"given":"Tannaz","family":"Dehghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Daneshvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sama","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parya","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Afkhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kohansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Javanmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-8163","authenticated-orcid":false,"given":"Vahdat","family":"Poortahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"issue":"2","key":"3305_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000506200","volume":"5","author":"A Vernon-Roberts","year":"2020","unstructured":"Vernon-Roberts A et al (2020) Validation of a revised knowledge assessment tool for children with inflammatory bowel disease (IBD-KID2). Inflamm Intest Dis 5(2):70\u201377","journal-title":"Inflamm Intest Dis"},{"issue":"2","key":"3305_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/gastro\/goz004","volume":"7","author":"DJ Wong","year":"2019","unstructured":"Wong DJ et al (2019) Surgery in the age of biologics. Gastroenterol Rep 7(2):77\u201390. https:\/\/doi.org\/10.1093\/gastro\/goz004","journal-title":"Gastroenterol Rep"},{"key":"3305_CR3","doi-asserted-by":"publisher","unstructured":"Ghione S et al (2018) Dramatic increase in incidence of ulcerative colitis and Crohn\u2019s disease (1988\u20132011): a population-based study of French adolescents. Off J Am Coll Gastroenterol ACG 113(2): 265-272. https:\/\/doi.org\/10.1038\/ajg.2017.228","DOI":"10.1038\/ajg.2017.228"},{"issue":"1","key":"3305_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.advms.2016.09.001","volume":"62","author":"Z Kmie\u0107","year":"2017","unstructured":"Kmie\u0107 Z, Cyman M, \u015alebioda TJ (2017) Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci 62(1):1\u201316. https:\/\/doi.org\/10.1016\/j.advms.2016.09.001","journal-title":"Adv Med Sci"},{"key":"3305_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2023.2185510","author":"G Mocci","year":"2023","unstructured":"Mocci G et al (2023) Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn\u2019s disease: results from an Italian multicenter study. Expert Opin Biol Ther. https:\/\/doi.org\/10.1080\/14712598.2023.2185510","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"3305_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cgh.2019.07.005","volume":"18","author":"C Le Berre","year":"2020","unstructured":"Le Berre C et al (2020) Ulcerative colitis and Crohn\u2019s disease have similar burden and goals for treatment. Clin Gastroenterol Hepatol 18(1):14\u201323. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3305_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-021-00829-9","volume":"7","author":"L Sweeney","year":"2021","unstructured":"Sweeney L et al (2021) Pain management in inflammatory bowel disease: feasibility of an online therapist-supported CBT-based self-management intervention. Pilot Feasibility Stud 7(1):1\u201315. https:\/\/doi.org\/10.1186\/s40814-021-00829-9","journal-title":"Pilot Feasibility Stud"},{"key":"3305_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00942","author":"M Zhang","year":"2017","unstructured":"Zhang M et al (2017) Interactions between Intestinal Microbiota and Host Immune Response in inflammatory bowel disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.00942","journal-title":"Front Immunol"},{"issue":"5","key":"3305_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5152\/tjg.2019.18466","volume":"30","author":"HS Lee","year":"2019","unstructured":"Lee HS, Lee KJ (2019) Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and Crohn\u2019s disease. Turk J Gastroenterol 30(5):408. https:\/\/doi.org\/10.5152\/tjg.2019.18466","journal-title":"Turk J Gastroenterol"},{"issue":"2","key":"3305_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1053\/j.gastro.2021.03.064","volume":"161","author":"KL Alexander","year":"2021","unstructured":"Alexander KL et al (2021) Human microbiota flagellins drive adaptive immune responses in Crohn\u2019s disease. Gastroenterology 161(2):522-535.e6. https:\/\/doi.org\/10.1053\/j.gastro.2021.03.064","journal-title":"Gastroenterology"},{"issue":"5","key":"3305_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00535-015-1064-1","volume":"50","author":"D Sheehan","year":"2015","unstructured":"Sheehan D, Moran C, Shanahan F (2015) The microbiota in inflammatory bowel disease. J Gastroenterol 50(5):495\u2013507. https:\/\/doi.org\/10.1007\/s00535-015-1064-1","journal-title":"J Gastroenterol"},{"issue":"10","key":"3305_CR12","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/ibd\/izab029","volume":"27","author":"S Dharmasiri","year":"2021","unstructured":"Dharmasiri S et al (2021) Human intestinal macrophages are involved in the pathology of both ulcerative colitis and Crohn disease. Inflamm Bowel Dis 27(10):1641\u20131652. https:\/\/doi.org\/10.1093\/ibd\/izab029","journal-title":"Inflamm Bowel Dis"},{"key":"3305_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2018.08.010","volume":"335","author":"LJ Lai","year":"2019","unstructured":"Lai LJ, Shen J, Ran ZH (2019) Natural killer T cells and ulcerative colitis. Cell Immunol 335:1\u20135. https:\/\/doi.org\/10.1016\/j.cellimm.2018.08.010","journal-title":"Cell Immunol"},{"issue":"2","key":"3305_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.gastro.2020.04.074","volume":"159","author":"V Mitsialis","year":"2020","unstructured":"Mitsialis V et al (2020) Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn\u2019s disease. Gastroenterology 159(2):591-608.e10. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.074","journal-title":"Gastroenterology"},{"key":"3305_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21037\/tgh.2019.10.14","volume":"5","author":"K Mushtaq","year":"2020","unstructured":"Mushtaq K et al (2020) Trends and outcomes of fungal infections in hospitalized patients of inflammatory bowel disease: a nationwide analysis. Transl Gastroenterol Hepatol 5:35\u201335. https:\/\/doi.org\/10.21037\/tgh.2019.10.14","journal-title":"Transl Gastroenterol Hepatol"},{"key":"3305_CR16","volume-title":"Cytomegaloviruses. Rinderpest Virus. Lumpy Skin Disease Virus","author":"K Weiss","year":"2013","unstructured":"Weiss K, Gard S (2013) Cytomegaloviruses. Rinderpest Virus. Lumpy Skin Disease Virus. Springer, New York"},{"issue":"3","key":"3305_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00054725-200405000-00011","volume":"10","author":"DW Hommes","year":"2004","unstructured":"Hommes DW et al (2004) The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 10(3):245\u2013250. https:\/\/doi.org\/10.1097\/00054725-200405000-00011","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"3305_CR18","doi-asserted-by":"publisher","first-page":"101625","DOI":"10.1016\/j.clinre.2021.101625","volume":"45","author":"T Temtem","year":"2021","unstructured":"Temtem T et al (2021) Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis. Clin Res Hepatol Gastroenterol 45(6):101625. https:\/\/doi.org\/10.1016\/j.clinre.2021.101625","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3305_CR19","doi-asserted-by":"publisher","DOI":"10.1159\/000514715","author":"T Leal","year":"2021","unstructured":"Leal T et al (2021) Colitis due to cytomegalovirus and herpes simplex type 2 as a complication of a first presentation of inflammatory bowel disease. GE Port J Gastroenterol. https:\/\/doi.org\/10.1159\/000514715","journal-title":"GE Port J Gastroenterol"},{"issue":"7","key":"3305_CR20","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/microorganisms8071078","volume":"8","author":"A Jentzer","year":"2020","unstructured":"Jentzer A et al (2020) Cytomegalovirus and inflammatory bowel diseases (IBD) with a special focus on the link with ulcerative colitis (UC). Microorganisms 8(7):1078. https:\/\/doi.org\/10.3390\/microorganisms8071078","journal-title":"Microorganisms"},{"key":"3305_CR21","doi-asserted-by":"publisher","unstructured":"Ibsen P 18F-FDG PET\/CT Findings in Cytomegalovirus Colitis. https:\/\/doi.org\/10.3390\/diagnostics9010003","DOI":"10.3390\/diagnostics9010003"},{"key":"3305_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-0716-1987-2_8","volume-title":"Management of Inpatient Inflammatory Bowel Disease","author":"SE Ouali","year":"2022","unstructured":"Ouali SE, Achkar J-P (2022) Management of Hospitalized Patients with Inflammatory Bowel Disease and CMV Infection or Clostridium Difficile Infection. Management of Inpatient Inflammatory Bowel Disease. Springer, New York, pp 161\u2013180"},{"issue":"2","key":"3305_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/17474124.2022.2032662","volume":"16","author":"A Jena","year":"2022","unstructured":"Jena A et al (2022) Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment. Expert Rev Gastroenterol Hepatol 16(2):109\u2013120. https:\/\/doi.org\/10.1080\/17474124.2022.2032662","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"3305_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14740\/gr1588","volume":"16","author":"A Thavamani","year":"2023","unstructured":"Thavamani A et al (2023) Cytomegalovirus infection is associated with adverse outcomes among hospitalized pediatric patients with inflammatory bowel disease. Gastroenterol Res 16(1):1\u20138. https:\/\/doi.org\/10.14740\/gr1588","journal-title":"Gastroenterol Res"},{"issue":"1","key":"3305_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-022-02944-7","volume":"13","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S et al (2022) Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. Stem Cell Res Ther 13(1):257. https:\/\/doi.org\/10.1186\/s13287-022-02944-7","journal-title":"Stem Cell Res Ther"},{"key":"3305_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/978-981-19-7656-8_25","volume-title":"Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases","author":"S Yasamineh","year":"2023","unstructured":"Yasamineh S et al (2023) Future Prospects of Natural Polymer-Based Drug Delivery Systems in Combating Lung Diseases. Natural Polymeric Materials based Drug Delivery Systems in Lung Diseases. Springer, Singapore, pp 465\u2013482"},{"issue":"1","key":"3305_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12951-022-01625-0","volume":"20","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh S et al (2022) An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J Nanobiotechnol 20(1):440. https:\/\/doi.org\/10.1186\/s12951-022-01625-0","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"3305_CR28","doi-asserted-by":"publisher","first-page":"100267","DOI":"10.1016\/j.infpip.2022.100267","volume":"5","author":"A Amiot","year":"2023","unstructured":"Amiot A et al (2023) Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study. Infect Prev Pract 5(1):100267. https:\/\/doi.org\/10.1016\/j.infpip.2022.100267","journal-title":"Infect Prev Pract"},{"issue":"10","key":"3305_CR29","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/ibd\/izaa170","volume":"26","author":"M Aziz","year":"2020","unstructured":"Aziz M et al (2020) The incidence and outcomes of COVID-19 in IBD patients: a rapid review and meta-analysis. Inflamm Bowel Dis 26(10):e132\u2013e133. https:\/\/doi.org\/10.1093\/ibd\/izaa170","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"3305_CR30","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cgh.2020.07.036","volume":"19","author":"TP Hanrahan","year":"2021","unstructured":"Hanrahan TP, Lubel JS, Garg M (2021) Lessons From COVID-19, ACE2, and Intestinal Inflammation: could a virus trigger Chronic Intestinal Inflammation? Clin Gastroenterol Hepatol 19(1):206. https:\/\/doi.org\/10.1016\/j.cgh.2020.07.036","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"3305_CR31","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/gutjnl-2020-321269","volume":"69","author":"MF Neurath","year":"2020","unstructured":"Neurath MF (2020) COVID-19 and immunomodulation in IBD. Gut 69(7):1335. https:\/\/doi.org\/10.1136\/gutjnl-2020-321269","journal-title":"Gut"},{"issue":"1","key":"3305_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.gastro.2020.07.067","volume":"160","author":"JM Penninger","year":"2021","unstructured":"Penninger JM, Grant MB, Sung JJ (2021) The role of angiotensin converting enzyme 2 in modulating gut microbiota, intestinal inflammation, and coronavirus infection. Gastroenterology 160(1):39\u201346. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.067","journal-title":"Gastroenterology"},{"key":"3305_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-021-01567-z","author":"MJ McAllister","year":"2022","unstructured":"McAllister MJ et al (2022) Intestinal protein characterisation of SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in inflammatory bowel disease (IBD) and fatal COVID-19 infection. Inflammation. https:\/\/doi.org\/10.1007\/s10753-021-01567-z","journal-title":"Inflammation"},{"key":"3305_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa185","author":"B Verstockt","year":"2020","unstructured":"Verstockt B et al (2020) Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue is downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon. biorxiv. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa185","journal-title":"biorxiv"},{"key":"3305_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-022-01310-y","author":"B Kante","year":"2023","unstructured":"Kante B et al (2023) High seroprevalence against SARS-Cov-2 in non-vaccinated patients with inflammatory bowel disease from Northern India. Indian J Gastroenterol. https:\/\/doi.org\/10.1007\/s12664-022-01310-y","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"3305_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s2468-1253(22)00389-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z et al (2023) Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA. 1 and BA. 4\/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. Lancet Gastroenterol Hepatol 8(2):145\u2013156. https:\/\/doi.org\/10.1016\/s2468-1253(22)00389-2","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"3305_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gutjnl-2022-327570","volume":"72","author":"NA Kennedy","year":"2023","unstructured":"Kennedy NA et al (2023) Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic. Gut 72(2):295\u2013305. https:\/\/doi.org\/10.1136\/gutjnl-2022-327570","journal-title":"Gut"},{"issue":"1","key":"3305_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5152\/imj.2018.93357","volume":"19","author":"M \u00c7olak","year":"2018","unstructured":"\u00c7olak M et al (2018) Relationship between Epstein-Barr Virus (EBV) infection and viral load in Immunosuppressive patients. Istanbul Med J 19(1):7\u201313. https:\/\/doi.org\/10.5152\/imj.2018.93357","journal-title":"Istanbul Med J"},{"issue":"2","key":"3305_CR39","doi-asserted-by":"publisher","first-page":"e1009210","DOI":"10.1371\/journal.ppat.1009210","volume":"17","author":"N Wallaschek","year":"2021","unstructured":"Wallaschek N et al (2021) Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids. PLoS Pathogens 17(2):e1009210. https:\/\/doi.org\/10.1371\/journal.ppat.1009210","journal-title":"PLoS Pathogens"},{"issue":"13","key":"3305_CR40","doi-asserted-by":"publisher","first-page":"e00088","DOI":"10.1128\/jvi.00088-21","volume":"95","author":"F Lu","year":"2021","unstructured":"Lu F et al (2021) Defective Epstein-Barr Virus Genomes and atypical viral gene expression in B-cell lines derived from multiple Myeloma patients. J Virol 95(13):e00088-e121. https:\/\/doi.org\/10.1128\/jvi.00088-21","journal-title":"J Virol"},{"issue":"7","key":"3305_CR41","doi-asserted-by":"publisher","first-page":"e0200546","DOI":"10.1371\/journal.pone.0200546","volume":"13","author":"N Salloum","year":"2018","unstructured":"Salloum N et al (2018) Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9. PLoS One 13(7):e0200546. https:\/\/doi.org\/10.1371\/journal.pone.0200546","journal-title":"PLoS One"},{"issue":"7","key":"3305_CR42","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/v13071272","volume":"13","author":"S Andari","year":"2021","unstructured":"Andari S et al (2021) Epstein-Barr virus DNA exacerbates Colitis symptoms in a Mouse model of inflammatory bowel disease. Viruses 13(7):1272. https:\/\/doi.org\/10.3390\/v13071272","journal-title":"Viruses"},{"issue":"9","key":"3305_CR43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/meg.0000000000001474","volume":"31","author":"S Wu","year":"2019","unstructured":"Wu S et al (2019) A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease. Eur J Gastroenterol Hepatol 31(9):1085\u20131091. https:\/\/doi.org\/10.1097\/meg.0000000000001474","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"3305_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12328-020-01319-w","volume":"14","author":"S Kato","year":"2021","unstructured":"Kato S et al (2021) Substantial Epstein-Barr virus reactivation in a case of severe refractory ulcerative colitis: a possible role in exacerbation. Clin J Gastroenterol 14(2):584\u2013588. https:\/\/doi.org\/10.1007\/s12328-020-01319-w","journal-title":"Clin J Gastroenterol"},{"issue":"33","key":"3305_CR45","first-page":"1859","volume":"149","author":"N Juffermans","year":"2005","unstructured":"Juffermans N et al (2005) Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease. Ned Tijdschr Geneeskd 149(33):1859\u20131863","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"3305_CR46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000489996","volume":"99","author":"X Li","year":"2019","unstructured":"Li X et al (2019) The status of Epstein-Barr virus infection in intestinal mucosa of Chinese patients with inflammatory bowel disease. Digestion 99(2):126\u2013132. https:\/\/doi.org\/10.1159\/000489996","journal-title":"Digestion"},{"issue":"1","key":"3305_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01395-9","volume":"20","author":"W Xu","year":"2020","unstructured":"Xu W et al (2020) Chronic active Epstein-Barr virus infection involving gastrointestinal tract mimicking inflammatory bowel disease. BMC Gastroenterol 20(1):1\u20137. https:\/\/doi.org\/10.1186\/s12876-020-01395-9","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"3305_CR48","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00384-019-03400-4","volume":"34","author":"Y Zhou","year":"2019","unstructured":"Zhou Y et al (2019) EBV-associated lymphoproliferative disorder involving the gastrointestinal tract which mimic IBD in immunocompetent patients: case reports and literature review. Int J Colorectal Dis 34(11):1989\u20131993. https:\/\/doi.org\/10.1007\/s00384-019-03400-4","journal-title":"Int J Colorectal Dis"},{"key":"3305_CR49","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1016\/j.pathol.2017.11.056","volume":"50","author":"K Patton","year":"2018","unstructured":"Patton K et al (2018) Epstein-barr virus associated colitis: Another mimic of IBD? Pathology 50:S142. https:\/\/doi.org\/10.1016\/j.pathol.2017.11.056","journal-title":"Pathology"},{"issue":"5","key":"3305_CR50","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/mpg.0000000000001077","volume":"62","author":"J Gordon","year":"2016","unstructured":"Gordon J et al (2016) EBV status and thiopurine use in pediatric IBD. J Pediatr Gastroenterol Nutr 62(5):711\u2013714. https:\/\/doi.org\/10.1097\/mpg.0000000000001077","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"3305_CR51","first-page":"485","volume":"10","author":"R Kocwa-Haluch","year":"2001","unstructured":"Kocwa-Haluch R (2001) Waterborne enteroviruses as a hazard for human health. Pol J Environ Stud 10(6):485\u2013488","journal-title":"Pol J Environ Stud"},{"issue":"27","key":"3305_CR52","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.3748\/wjg.v27.i27.4276","volume":"27","author":"V Craviotto","year":"2021","unstructured":"Craviotto V et al (2021) Viral infections in inflammatory bowel disease: tips and tricks for correct management. World J Gastroenterol 27(27):4276. https:\/\/doi.org\/10.3748\/wjg.v27.i27.4276","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3305_CR53","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1038\/ctg.2013.7","volume":"4","author":"N Nystr\u00f6m","year":"2013","unstructured":"Nystr\u00f6m N et al (2013) Human enterovirus species B in ileocecal Crohn\u2019s disease. Clin Transl Gastroenterol 4(6):e38. https:\/\/doi.org\/10.1038\/ctg.2013.7","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"3305_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep25017","volume":"6","author":"S Lei","year":"2016","unstructured":"Lei S et al (2016) Enterobacter cloacae inhibits human norovirus infectivity in gnotobiotic pigs. Sci Rep 6(1):1\u201310. https:\/\/doi.org\/10.1038\/srep25017","journal-title":"Sci Rep"},{"issue":"10","key":"3305_CR55","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41395-018-0211-8","volume":"113","author":"JE Axelrad","year":"2018","unstructured":"Axelrad JE et al (2018) Enteric infections are common in patients with flares of inflammatory bowel disease. Am J Gastroenterol 113(10):1530. https:\/\/doi.org\/10.1038\/s41395-018-0211-8","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"3305_CR56","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/apt.15770","volume":"51","author":"JE Axelrad","year":"2020","unstructured":"Axelrad JE et al (2020) Systematic review: gastrointestinal infection and incident inflammatory bowel disease. Aliment Pharmacol Ther 51(12):1222\u20131232. https:\/\/doi.org\/10.1111\/apt.15770","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3305_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/v13010104","volume":"13","author":"G Tarris","year":"2021","unstructured":"Tarris G et al (2021) Enteric viruses and inflammatory bowel disease. Viruses 13(1):104. https:\/\/doi.org\/10.3390\/v13010104","journal-title":"Viruses"},{"issue":"4","key":"3305_CR58","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.immuni.2016.03.009","volume":"44","author":"J-Y Yang","year":"2016","unstructured":"Yang J-Y et al (2016) Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-\u03b2 production. Immunity 44(4):889\u2013900. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.009","journal-title":"Immunity"},{"issue":"2","key":"3305_CR59","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jcv.2004.09.031","volume":"33","author":"L Rodriguez-Guillen","year":"2005","unstructured":"Rodriguez-Guillen L et al (2005) Calicivirus infection in human immunodeficiency virus seropositive children and adults. J Clin Virol 33(2):104\u2013109. https:\/\/doi.org\/10.1016\/j.jcv.2004.09.031","journal-title":"J Clin Virol"},{"issue":"1","key":"3305_CR60","doi-asserted-by":"publisher","first-page":"13485","DOI":"10.1038\/s41598-021-92796-7","volume":"11","author":"KH Hamza","year":"2021","unstructured":"Hamza KH et al (2021) Minor alterations in the intestinal microbiota composition upon Rotavirus infection do not affect susceptibility to DSS colitis. Sci Rep 11(1):13485. https:\/\/doi.org\/10.1038\/s41598-021-92796-7","journal-title":"Sci Rep"},{"key":"3305_CR61","unstructured":"LeClair CE and DP Budh (2021) Rotavirus. StatPearls [Internet]"},{"issue":"27","key":"3305_CR62","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1016\/j.vaccine.2021.05.032","volume":"39","author":"E Liles","year":"2021","unstructured":"Liles E et al (2021) Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine 39(27):3614\u20133620. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.032","journal-title":"Vaccine"},{"key":"3305_CR63","doi-asserted-by":"publisher","DOI":"10.29245\/2578-3009\/2020\/4.1195","author":"RC Smith","year":"2020","unstructured":"Smith RC et al (2020) Is Rotavirus immunization safe in infants born to mothers treated with immunosuppressive drugs for inflammatory bowel disease during pregnancy? J Immunol Scie. https:\/\/doi.org\/10.29245\/2578-3009\/2020\/4.1195","journal-title":"J Immunol Scie"},{"key":"3305_CR64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.antiviral.2018.06.011","volume":"156","author":"Y Yin","year":"2018","unstructured":"Yin Y et al (2018) 6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP\/GTP cycling. Antiviral Res 156:92\u2013101. https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.011","journal-title":"Antiviral Res"},{"issue":"50","key":"3305_CR65","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2807\/esw.11.50.03093-en","volume":"11","author":"A Kroneman","year":"2006","unstructured":"Kroneman A et al (2006) Increase in norovirus activity reported in Europe. Weekly releases (1997\u20132007) 11(50):3093. https:\/\/doi.org\/10.2807\/esw.11.50.03093-en","journal-title":"Weekly releases (1997\u20132007)"},{"issue":"5","key":"3305_CR66","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1080\/19490976.2020.1754714","volume":"11","author":"MA Engevik","year":"2020","unstructured":"Engevik MA et al (2020) Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence. Gut microbes 11(5):1324\u20131347. https:\/\/doi.org\/10.1080\/19490976.2020.1754714","journal-title":"Gut microbes"},{"issue":"1","key":"3305_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-92796-7","volume":"11","author":"KH Hamza","year":"2021","unstructured":"Hamza KH et al (2021) Minor alterations in the intestinal microbiota composition upon Rotavirus infection do not affect susceptibility to DSS colitis. Sci Rep 11(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-021-92796-7","journal-title":"Sci Rep"},{"issue":"10","key":"3305_CR68","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/v13102069","volume":"13","author":"B Zhao","year":"2021","unstructured":"Zhao B et al (2021) Norovirus protease structure and antivirals development. Viruses 13(10):2069. https:\/\/doi.org\/10.3390\/v13102069","journal-title":"Viruses"},{"issue":"5","key":"3305_CR69","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.4049\/jimmunol.1801069","volume":"202","author":"H-A Ting","year":"2019","unstructured":"Ting H-A, von Moltke J (2019) The immune function of tuft cells at gut mucosal surfaces and beyond. J Immunol 202(5):1321\u20131329. https:\/\/doi.org\/10.4049\/jimmunol.1801069","journal-title":"J Immunol"},{"key":"3305_CR70","doi-asserted-by":"publisher","unstructured":"Lei S et al (2019) Enhanced GII. 4 human norovirus infection in gnotobiotic pigs transplanted with a human gut microbiota. J Gen Virol 100(11): 1530. https:\/\/doi.org\/10.1099\/jgv.0.001336","DOI":"10.1099\/jgv.0.001336"},{"issue":"1","key":"3305_CR71","doi-asserted-by":"publisher","first-page":"e01185","DOI":"10.1128\/msphere.01185-20","volume":"6","author":"G Tarris","year":"2021","unstructured":"Tarris G et al (2021) Specific norovirus interaction with Lewis x and Lewis a on human intestinal inflammatory mucosa during refractory inflammatory bowel disease. Msphere 6(1):e01185-e1220. https:\/\/doi.org\/10.1128\/msphere.01185-20","journal-title":"Msphere"},{"issue":"3","key":"3305_CR72","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/mpg.0b013e31818255cc","volume":"48","author":"RR Khan","year":"2009","unstructured":"Khan RR et al (2009) Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 48(3):328\u2013333. https:\/\/doi.org\/10.1097\/mpg.0b013e31818255cc","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3305_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4263309","author":"O Gholizadeh","year":"2023","unstructured":"Gholizadeh O et al (2023) Hepatitis A: viral structure, classification, life cycle, clinical symptoms, diagnosis error, and vaccination. Can J Infect Dis Med Microbiol. https:\/\/doi.org\/10.1155\/2023\/4263309","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"3305_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.105995","author":"O Gholizadeh","year":"2023","unstructured":"Gholizadeh O et al (2023) The role of non-coding RNAs in the diagnosis of different stages (HCC, CHB, OBI) of hepatitis B infection. Microb Pathog. https:\/\/doi.org\/10.1016\/j.micpath.2023.105995","journal-title":"Microb Pathog"},{"issue":"2","key":"3305_CR75","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","volume":"37","author":"WH Organization","year":"2019","unstructured":"Organization WH (2019) Hepatitis B vaccines: WHO position paper, July 2017\u2013Recommendations. Vaccine 37(2):223\u2013225. https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.046","journal-title":"Vaccine"},{"issue":"2","key":"3305_CR76","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.crohns.2012.03.001","volume":"7","author":"A Papa","year":"2013","unstructured":"Papa A et al (2013) Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-\u03b1 agents. J Crohns Colitis 7(2):113\u2013119. https:\/\/doi.org\/10.1016\/j.crohns.2012.03.001","journal-title":"J Crohns Colitis"},{"issue":"10","key":"3305_CR77","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/gut.2010.217331","volume":"59","author":"L Beaugerie","year":"2010","unstructured":"Beaugerie L, Gerbes AL (2010) Liver dysfunction in patients with IBD under immunosuppressive treatment: do we need to fear? Gut 59(10):1310\u20131311. https:\/\/doi.org\/10.1136\/gut.2010.217331","journal-title":"Gut"},{"issue":"11","key":"3305_CR78","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/pathogens9110870","volume":"9","author":"G Losurdo","year":"2020","unstructured":"Losurdo G et al (2020) Chronic Viral Hepatitis in a Cohort of inflammatory bowel disease patients from southern italy: a case-control study. Pathogens 9(11):870. https:\/\/doi.org\/10.3390\/pathogens9110870","journal-title":"Pathogens"},{"issue":"1","key":"3305_CR79","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/ijms23010500","volume":"23","author":"FP Russo","year":"2022","unstructured":"Russo FP et al (2022) Hepatocellular Carcinoma in Chronic Viral Hepatitis: where do we stand? Int J Mol Sci 23(1):500. https:\/\/doi.org\/10.3390\/ijms23010500","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3305_CR80","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s10620-019-05595-6","volume":"64","author":"PK Pratt","year":"2019","unstructured":"Pratt PK et al (2019) Improved antibody response to three additional hepatitis B vaccine doses following primary vaccination failure in patients with inflammatory bowel disease. Dig Dis Sci 64(7):2031\u20132038. https:\/\/doi.org\/10.1007\/s10620-019-05595-6","journal-title":"Dig Dis Sci"},{"key":"3305_CR81","unstructured":"Kalogera D et al Complications related to varicella zoster virus infection in patients with inflammatory bowel disease in the pre-JAK inhibitors era: A prospective study. https:\/\/www.researchgate.net\/profile\/Isabel-Perez-Martinez-2\/publication\/322889992_P377_Complications_related_to_varicella_zoster_virus_infection_in_patients_with_inflammatory_bowel_disease_in_the_pre-JAK_inhibitors_era_A_prospective_study\/links\/5cabbb27299bf118c4bcf8f4\/P377-Complications-related-to-varicella-zoster-virus-infection-in-patientswith-inflammatory-bowel-disease-in-the-pre-JAK-inhibitors-era-A-prospective-study.pdf"},{"key":"3305_CR82","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000000940","author":"C Cekic","year":"2015","unstructured":"Cekic C et al (2015) Evaluation of factors associated with response to hepatitis B vaccination in patients with inflammatory bowel disease. Medicine. https:\/\/doi.org\/10.1097\/md.0000000000000940","journal-title":"Medicine"},{"issue":"10","key":"3305_CR83","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/ibd\/izaa353","volume":"27","author":"GS Kochhar","year":"2021","unstructured":"Kochhar GS et al (2021) Hepatitis-B vaccine response in inflammatory bowel disease patients: a systematic review and meta-analysis. Inflamm Bowel Dis 27(10):1610\u20131619. https:\/\/doi.org\/10.1093\/ibd\/izaa353","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"3305_CR84","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/v14020244","volume":"14","author":"LM Forero-Junco","year":"2022","unstructured":"Forero-Junco LM et al (2022) Bacteriophages roam the wheat phyllosphere. Viruses 14(2):244. https:\/\/doi.org\/10.3390\/v14020244","journal-title":"Viruses"},{"issue":"2","key":"3305_CR85","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/v14020278","volume":"14","author":"G-H Bai","year":"2022","unstructured":"Bai G-H et al (2022) The Human Virome: viral metagenomics, relations with human diseases, and therapeutic applications. Viruses 14(2):278. https:\/\/doi.org\/10.3390\/v14020278","journal-title":"Viruses"},{"issue":"1","key":"3305_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40168-018-0452-1","volume":"6","author":"JK Cornuault","year":"2018","unstructured":"Cornuault JK et al (2018) Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes. Microbiome 6(1):65. https:\/\/doi.org\/10.1186\/s40168-018-0452-1","journal-title":"Microbiome"},{"issue":"40","key":"3305_CR87","doi-asserted-by":"publisher","first-page":"11321","DOI":"10.3748\/wjg.v21.i40.11321","volume":"21","author":"J Babickova","year":"2015","unstructured":"Babickova J, Gardlik R (2015) Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol: WJG 21(40):11321. https:\/\/doi.org\/10.3748\/wjg.v21.i40.11321","journal-title":"World J Gastroenterol: WJG"},{"issue":"6","key":"3305_CR88","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.chom.2019.10.009","volume":"26","author":"AG Clooney","year":"2019","unstructured":"Clooney AG et al (2019) Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease. Cell Host Microbe 26(6):764-778.e5. https:\/\/doi.org\/10.1016\/j.chom.2019.10.009","journal-title":"Cell Host Microbe"},{"issue":"1","key":"3305_CR89","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/mpg.0000000000002140","volume":"68","author":"MA Fernandes","year":"2019","unstructured":"Fernandes MA et al (2019) Enteric virome and bacterial microbiota in children with ulcerative colitis and crohn disease. J Pediatr Gastroenterol Nutr 68(1):30\u201336. https:\/\/doi.org\/10.1097\/mpg.0000000000002140","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3305_CR90","doi-asserted-by":"publisher","first-page":"175628481983662","DOI":"10.1177\/1756284819836620","volume":"12","author":"I Mukhopadhya","year":"2019","unstructured":"Mukhopadhya I et al (2019) The gut virome: the \u2018missing link\u2019between gut bacteria and host immunity? Adv Gastroenterol 12:1756284819836620. https:\/\/doi.org\/10.1177\/1756284819836620","journal-title":"Adv Gastroenterol"},{"issue":"10","key":"3305_CR91","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1177\/09596836211025975","volume":"31","author":"VI Glazko","year":"2021","unstructured":"Glazko VI et al (2021) Domestication and microbiome. Holocene 31(10):1635\u20131645. https:\/\/doi.org\/10.1177\/09596836211025975","journal-title":"Holocene"},{"issue":"11","key":"3305_CR92","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/microorganisms8111663","volume":"8","author":"H Nishiyama","year":"2020","unstructured":"Nishiyama H et al (2020) Ecological structuring of temperate bacteriophages in the inflammatory Bowel Disease-affected gut. Microorganisms 8(11):1663. https:\/\/doi.org\/10.3390\/microorganisms8111663","journal-title":"Microorganisms"},{"key":"3305_CR93","doi-asserted-by":"crossref","unstructured":"Farahmandzad F et al (2022) Bacteriophages in gut microbiome interactions in patients with inflammatory Bowel Disease: differences by sex and the disease type. https:\/\/www.researchsquare.com\/article\/rs-1240997\/latest.pdf","DOI":"10.21203\/rs.3.rs-1240997\/v1"},{"issue":"12","key":"3305_CR94","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/ibd.22950","volume":"18","author":"G Cullen","year":"2012","unstructured":"Cullen G, Baden RP, Cheifetz AS (2012) Varicella Zoster virus infection in inflammatory bowel disease. Inflamm Bowel Dis 18(12):2392\u20132403. https:\/\/doi.org\/10.1002\/ibd.22950","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"3305_CR95","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ecco-jcc\/jjab232.416","volume":"16","author":"A Martin Cardona","year":"2022","unstructured":"Martin Cardona A et al (2022) P289 Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: national multicenter study (ENEIDA registry). MIC project. J Crohn\u2019s Colitis 16(1):321\u2013322. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab232.416","journal-title":"J Crohn's Colitis"},{"issue":"5","key":"3305_CR96","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.4103\/jfmpc.jfmpc_1871_21","volume":"11","author":"MH Mosli","year":"2022","unstructured":"Mosli MH et al (2022) Human papillomavirus bowel colonization in inflammatory bowel disease: a comparative case control study. J Fam Med Prim Care 11(5):1863. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1871_21","journal-title":"J Fam Med Prim Care"},{"key":"3305_CR97","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13893","author":"CJ Wang","year":"2020","unstructured":"Wang CJ, Truong AK (2020) COVID-19 infection on IL-23 inhibition. Dermatol Ther. https:\/\/doi.org\/10.1111\/dth.13893","journal-title":"Dermatol Ther"},{"issue":"1","key":"3305_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14740338.2021.1980536","volume":"21","author":"J Miyoshi","year":"2022","unstructured":"Miyoshi J, Matsuura M, Hisamatsu T (2022) Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis. Expert Opin Drug Saf 21(1):1\u20138. https:\/\/doi.org\/10.1080\/14740338.2021.1980536","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"3305_CR99","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.cgh.2018.04.033","volume":"16","author":"MP Pauly","year":"2018","unstructured":"Pauly MP et al (2018) Incidence of hepatitis B virus reactivation and hepatotoxicity in patients receiving long-term treatment with tumor necrosis factor antagonists. Clin Gastroenterol Hepatol 16(12):1964-1973.e1. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.033","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"3305_CR100","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/jcm9051273","volume":"9","author":"K Yeshi","year":"2020","unstructured":"Yeshi K et al (2020) Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products. J Clin Med 9(5):1273. https:\/\/doi.org\/10.3390\/jcm9051273","journal-title":"J Clin Med"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03305-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03305-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03305-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:36:38Z","timestamp":1744212998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03305-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03305-0","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflicts of interest regarding the research, authorship, and publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"195"}}